Initiation of noninsulin second-line Antidiabetics fraught with risk of discontinuation within one year: Study Dr. Kamal Kant Kohli18 Dec 2023 12:30 AM ISTUSA: Adherence to second-line diabetes drugs can be hit or miss among patients with type 2 diabetes, a recent study has reported.The findings...
Citing voglibose, sitagliptin incompatibility, CDSCO panel rejects Hetero Labs proposal for antidiabetic FDC drug Medical Dialogues Team13 March 2021 6:50 PM ISTNew Delhi: In a setback to Hetero Labs, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO)...
Long-term use of metformin may reduce breast cancer risk in diabetes patients Dr. Kamal Kant Kohli29 Jan 2021 7:18 AM ISTResearchers have found in a new study that long-term use of metformin may reduce breast cancer risk associated with T2D. In the study metformin use in...
Do sulfonylureas still have a role in blood sugar and diabetes control? Dr. Kamal Kant Kohli11 Jun 2020 12:45 PM ISTAt present, there are a large number of pharmacological agents available for good control of blood sugar and effectively treat type 2 diabetes...
